Fact CheckerSign in

NCT07671092RecruitingEarly phase 1

Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC

A Phase 0 Imaging Study to Assess the Feasibility, Biodistribution, and Dosimetry of the Imaging Agent in Metastatic Urothelial Cancer (UC), Hormone Receptor-Positive (HR+) and Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Breast Cancer, Triple-Negative Breast Cancer (TNBC), and Non-Small-Cell Lung Cancer (NSCLC)

Source: ClinicalTrials.gov · Last updated 13 Oct 2026

Brief summary (registry, in English)

This imaging study aims to assess the feasibility, biodistribution, and dosimetry of the imaging agent in subjects with metastatic UC, HR+ and HER2- breast cancer, TNBC, or NSCLC.

Status (registry)
Recruiting
Phase (registry)
Early phase 1
Study type
Interventional
Enrollment
40 (estimated)
First submitted
22 Jun 2026
Start date
15 Jun 2026
Primary completion date
Aug 2027
Lead sponsor
RayzeBio, Inc.
NCT number
NCT07671092

What you commit to

  • Study type: Interventional · Early phase 1
  • Planned participants: 40
  • From 15 Jun 2026 to the primary completion date, Aug 2027
  • 6 sites in 3 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • For Women of Childbearing Potential: Are pregnant or breastfeeding
    • Note: Additional criteria may apply and will be assessed by the study site

Who the study is looking for

  • Are at least 18 years old at the time of signing the informed consent form (ICF)
  • Have biopsy proven metastatic UC, HR+ and HER2- breast cancer, TNBC, or NSCLC

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (6)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
-
Coordinator of this site? Confirm its status
NedlandsAustraliaRecruiting
-
Coordinator of this site? Confirm its status
PerthAustraliaRecruiting
-
Coordinator of this site? Confirm its status
St LeonardsAustraliaRecruiting
-
Coordinator of this site? Confirm its status
ChristchurchNew ZealandRecruiting
-
Coordinator of this site? Confirm its status
JohannesburgSouth AfricaActive, not recruiting
-
Coordinator of this site? Confirm its status
PretoriaSouth AfricaActive, not recruiting

This page is information, not medical advice. Discuss any trial with your doctor.